Some visit links earn us a commission.

Ozempic vs Mounjaro cost: $349 vs $499 a month and up

Prices checked November 16, 2026

No insurance needed. Two programs to check.

Ozempic and Mounjaro are two different medicines approved for the same thing, type 2 diabetes. Ozempic is semaglutide from Novo Nordisk; Mounjaro is tirzepatide from Eli Lilly, which acts on a second gut hormone, GIP. Paying cash from the makers, Ozempic is $349 to $499 a month by dose and Mounjaro $499 a month.

Ozempic vs Mounjaro, side by side

Ozempic and Mounjaro compared on medicine, approval, cash price, savings card, Medicare and doses
OzempicMounjaro
Medicine
SemaglutideTirzepatide
Sold for cash by
NovoCare (Novo Nordisk)LillyDirect (Eli Lilly)
Approved for
Type 2 diabetes. Also lowers heart and kidney risk in people with type 2 diabetesType 2 diabetes
Cash price
$349 to $499 a month by dose$499 a month
Savings card, with commercial insurance
As low as $25/mo (max $100/mo off)As low as $25 for up to a 3-month Rx (annual max $1,950), until December 31, 2026
Medicare GLP-1 Bridge
Not includedNot included
Doses
0.5 mg, 1 mg or 2 mg, based on glycemic control. Highest dose 2 mg weeklyNo set maintenance dose. Highest dose 15 mg in adults

Cash prices are the makers' own, checked November 16. You need a prescription for either.

What each costs without insurance

Novo Nordisk sells Ozempic through NovoCare at $349 to $499 a month by dose. Eli Lilly sells Mounjaro through LillyDirect at $499 a month. Both need a prescription and neither store bills insurance.

Mounjaro shares its medicine and its strengths with Zepbound, Lilly's weight loss brand, which LillyDirect prices by dose. The full lists: Ozempic cost and Mounjaro cost.

What the head-to-head trial found

SURPASS-2 put the two side by side in 1,879 adults with type 2 diabetes for 40 weeks, against Ozempic's 1 mg dose. Blood sugar (A1c) fell 2.01 to 2.30 points on Mounjaro's three doses against 1.86 on semaglutide. Weight fell 7.6 to 11.2 kg against 5.7 kg.

The trial tested diabetes care, not weight loss, and Ozempic's 2 mg dose came later. Your prescriber weighs those results against your own history.

Insurance, Medicare and the savings cards

With type 2 diabetes, plans and Medicare Part D usually cover both, often after prior approval, and many list one as preferred. A plan's formulary decides which one costs you less.

With commercial insurance, each maker's card cuts the copay. Ozempic's card terms read as low as $25/mo (max $100/mo off). Mounjaro's read as low as $25 for up to a 3-month Rx (annual max $1,950), until December 31, 2026. Neither works with Medicare or Medicaid. Medicare's $50 GLP-1 Bridge covers neither brand.

Questions people ask

Is Ozempic cheaper than Mounjaro?
Paying cash from the makers, Ozempic is $349 to $499 a month by dose and Mounjaro $499 a month, so Ozempic costs less at its lowest price. With insurance, your plan's preferred brand usually costs less.
Are Ozempic and Mounjaro the same?
No. Ozempic is semaglutide and Mounjaro is tirzepatide, which acts on GIP as well as GLP-1. Both are once-weekly pens approved for type 2 diabetes.
Which lowers blood sugar more, Ozempic or Mounjaro?
In SURPASS-2, A1c fell 2.01 to 2.30 points on Mounjaro against 1.86 on Ozempic's 1 mg dose over 40 weeks.
Is there a savings card for Ozempic and Mounjaro?
Yes, for people with commercial insurance that covers the drug. Ozempic: as low as $25/mo (max $100/mo off). Mounjaro: as low as $25 for up to a 3-month Rx (annual max $1,950).

Compare other GLP-1 medications

Sources

Evidence checked November 9, 2026

Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.

3 documents

  1. What Ozempic is approved for and its dosesFDA prescribing information for Ozempic injection (DailyMed, revised June 2026)
  2. What Mounjaro is approved for and its dosesFDA prescribing information for Mounjaro (DailyMed, revised August 2026)
  3. SURPASS-2: tirzepatide against semaglutide 1 mg in type 2 diabetes, A1c and body weight at 40 weeksSURPASS-2, Frías et al., N Engl J Med 2021;385:503-515

Prices from NovoCare and LillyDirect and the makers' savings card pages, checked November 16. How we check prices.